Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 391 of 1,261
  1. US 10807987

    Heterocyclic compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Oct 20, 2020 · Expires Oct 15, 2040

    granted
  2. US 10806702

    Bis-polymer lipid-peptide conjugates and nanoparticles thereof

    The Regents of the University of California · Granted Oct 20, 2020 · Expires Oct 15, 2040

    granted
  3. US 10806791

    Carbohydrate conjugates as delivery agents for oligonucleotides

    Alnylam Pharmaceuticals, Inc. · Granted Oct 20, 2020 · Expires Oct 15, 2040

    granted
  4. US 10806781

    Compositions and methods for live, attenuated alphavirus formulations

    Takeda Vaccines, Inc. · Granted Oct 20, 2020 · Expires Oct 15, 2040

    granted
  5. US 10806780

    Anti-human papillomavirus (HPV) antigen-binding proteins and methods of use thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 20, 2020 · Expires Oct 15, 2040

    granted
  6. US 10806697

    Vaginal inserted estradiol pharmaceutical compositions and methods

    Compass Therapeutics LLC · Granted Oct 20, 2020 · Expires Oct 15, 2040

    granted
  7. US 10809323

    Magnetic resonance maps for analyzing tissue

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Oct 20, 2020 · Expires Oct 15, 2040

    granted
  8. US 10806742

    Liquid phospholipid-containing compositions for the preparation of pharmaceuticals

    AKER BIOMARINE ANTARCTIC AS · Granted Oct 20, 2020 · Expires Oct 15, 2040

    granted
  9. US 10808247

    Methods for treating neurological disorders using a synergistic small molecule and nucleic acids therapeutic approach

    Phio Pharmaceuticals Corp. · Granted Oct 20, 2020 · Expires Oct 15, 2040

    granted
  10. US 10806740

    Natural combination hormone replacement formulations and therapies

    Compass Therapeutics LLC · Granted Oct 20, 2020 · Expires Oct 15, 2040

    granted
  11. US 10808010

    Peptide inhibitors of phosphoglycerate mutase and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 20, 2020 · Expires Oct 15, 2040

    granted
  12. US 10806782

    Hand, foot, and mouth vaccines and methods of manufacture and use thereof

    Takeda Vaccines, Inc. · Granted Oct 20, 2020 · Expires Oct 15, 2040

    granted
  13. US 10806750

    RNAi therapy for hepatitis B virus infection

    Arrowhead Pharmaceuticals, Inc. · Granted Oct 20, 2020 · Expires Oct 15, 2040

    granted
  14. US 10806716

    Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity

    Auransa Inc. · Granted Oct 20, 2020 · Expires Oct 15, 2040

    granted
  15. US 10806763

    Compositions of polymeric myrcene

    REGENERA PHARMA LTD. · Granted Oct 20, 2020 · Expires Oct 15, 2040

    granted
  16. US 10806730

    Methods of treating cancer with farnesyltransferase inhibitors

    Kura Oncology, Inc. · Granted Oct 20, 2020 · Expires Oct 15, 2040

    granted
  17. US 10799468

    Methods and compositions for treating conditions associated with an abnormal inflammatory responses

    First Wave Bio, Inc. · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  18. US 10800769

    Heterocyclic inhibitors of ATR kinase

    The Board of Regents of the University of Texas System · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  19. US 10799485

    Methods and compositions for treatment of epileptic disorders

    OVID THERAPEUTICS INC. · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  20. US 10800813

    Modulation of structured polypeptide specificity

    BicycleRD Limited · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  21. US 10799573

    Pertussis vaccines and methods of making and using

    Regents of the University of Minnesota · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  22. US 10800854

    Chimeric cytokine receptors and encoding nucleic acids

    AUTOLUS LIMITED · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  23. US 10799567

    Yeast-based immunotherapy and type I interferon sensitivity

    The Regents of the University of Colorado · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  24. US 10799596

    Pyrrolobenzodiazepine-antibody conjugates

    ADC THERAPEUTICS SA · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.